Lv1
40 积分 2025-08-19 加入
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
6天前
已完结
A tumultuous journey that led to AI in cancer
9天前
已完结
‘Virtual cell’ captures the most-basic process of life: bacterial division
16天前
已完结
Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
17天前
已完结
Perioperative serplulimab with neoadjuvant chemotherapy versus perioperative chemotherapy in PD-L1-positive gastric cancer (ASTRUM-006): a randomised, double-blind, multicentre, phase 3 study
17天前
已完结
Revisiting the blueprint for an interpretable virtual cell
17天前
已完结
Harnessing artificial intelligence to advance CRISPR-based genome editing technologies
17天前
已完结
Towards multimodal foundation models in molecular cell biology
17天前
已完结
Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
20天前
已完结
The Definition of Cure in Colon Cancer
20天前
已完结
皖公网安备34019202002308
